Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Radiopharmaceuticals in Nuclear Medical industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Bracco Imaging
IBA Group
Taiyo Nippon Sanso Corporation
Siemens Healthcare
Ntp Radioisotopes
GE Healthcare (Subsidiary Of General Electric Company)
Urenco Limited
Nordion
Covidien
Eczacibasi-Monrol
Cardinal Health
Lantheus Medical Imaging
Fujifilm Holdings Corporation
By Type:
Enriched Stable Isotopes
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
By Application:
Diagnostic Application
Research
Therapeutic Application
Industrial
Pharmaceutical
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Radiopharmaceuticals in Nuclear Medical Market Overview 2018-2029
-
1.1 China Radiopharmaceuticals in Nuclear Medical Industry Development Overview
-
1.2 China Radiopharmaceuticals in Nuclear Medical Industry Development History
-
1.3 China Radiopharmaceuticals in Nuclear Medical Industry Market Size (2018-2029)
-
1.4 China Radiopharmaceuticals in Nuclear Medical Market Analysis by Type from Production Side
-
1.4.1 China Radiopharmaceuticals in Nuclear Medical Production Volume, Production Value and Growth Rate of Enriched Stable Isotopes (2018-2029)
-
1.4.2 China Radiopharmaceuticals in Nuclear Medical Production Volume, Production Value and Growth Rate of Diagnostic Radiopharmaceuticals (2018-2029)
-
1.4.3 China Radiopharmaceuticals in Nuclear Medical Production Volume, Production Value and Growth Rate of Therapy Radiopharmaceuticals (2018-2029)
-
1.5 China Radiopharmaceuticals in Nuclear Medical Market Analysis by Application from Consumption End
-
1.5.1 China Radiopharmaceuticals in Nuclear Medical Sales Volume, Sales Value and Growth Rate of Diagnostic Application (2018-2029)
-
1.5.2 China Radiopharmaceuticals in Nuclear Medical Sales Volume, Sales Value and Growth Rate of Research (2018-2029)
-
1.5.3 China Radiopharmaceuticals in Nuclear Medical Sales Volume, Sales Value and Growth Rate of Therapeutic Application (2018-2029)
-
1.5.4 China Radiopharmaceuticals in Nuclear Medical Sales Volume, Sales Value and Growth Rate of Industrial (2018-2029)
-
1.5.5 China Radiopharmaceuticals in Nuclear Medical Sales Volume, Sales Value and Growth Rate of Pharmaceutical (2018-2029)
-
1.6 China Radiopharmaceuticals in Nuclear Medical Market Analysis by Region
-
1.6.1 North China Radiopharmaceuticals in Nuclear Medical Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Radiopharmaceuticals in Nuclear Medical Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Radiopharmaceuticals in Nuclear Medical Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Radiopharmaceuticals in Nuclear Medical Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Radiopharmaceuticals in Nuclear Medical Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Radiopharmaceuticals in Nuclear Medical Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Radiopharmaceuticals in Nuclear Medical Market Size and Growth Rate from 2018-2029
Chapter 2 China Radiopharmaceuticals in Nuclear Medical Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Radiopharmaceuticals in Nuclear Medical Market Status and Competition at home and abroad in 2023
-
2.2.2 China Radiopharmaceuticals in Nuclear Medical Market Status and Competition Analysis in 2023
-
2.2.3 China Radiopharmaceuticals in Nuclear Medical Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Radiopharmaceuticals in Nuclear Medical Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Radiopharmaceuticals in Nuclear Medical Industry Development
Chapter 3 Radiopharmaceuticals in Nuclear MedicalIndustry Chain Analysis
-
3.1 Radiopharmaceuticals in Nuclear Medical Industry Chain
-
3.2 Radiopharmaceuticals in Nuclear Medical Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Radiopharmaceuticals in Nuclear Medical Market
-
3.3 Radiopharmaceuticals in Nuclear Medical Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Radiopharmaceuticals in Nuclear Medical Market
Chapter 4 China Radiopharmaceuticals in Nuclear Medical Market, by Type
-
4.1 China Radiopharmaceuticals in Nuclear Medical Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Radiopharmaceuticals in Nuclear Medical Total Production Volume and Growth Rate from Production Side
-
4.5 China Radiopharmaceuticals in Nuclear Medical Production Volume and Growth Rate, by Type
-
4.5.1 China Radiopharmaceuticals in Nuclear Medical Production Volume and Growth Rate of Enriched Stable Isotopes
-
4.5.2 China Radiopharmaceuticals in Nuclear Medical Production Volume and Growth Rate of Diagnostic Radiopharmaceuticals
-
4.5.3 China Radiopharmaceuticals in Nuclear Medical Production Volume and Growth Rate of Therapy Radiopharmaceuticals
Chapter 5 China Radiopharmaceuticals in Nuclear Medical Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Radiopharmaceuticals in Nuclear Medical Total Market Size and Growth Rate from Consumption End
-
5.5 China Radiopharmaceuticals in Nuclear Medical Market Size and Growth Rate, by Application
-
5.5.1 China Radiopharmaceuticals in Nuclear Medical Market Size and Growth Rate of Diagnostic Application
-
5.5.2 China Radiopharmaceuticals in Nuclear Medical Market Size and Growth Rate of Research
-
5.5.3 China Radiopharmaceuticals in Nuclear Medical Market Size and Growth Rate of Therapeutic Application
-
5.5.4 China Radiopharmaceuticals in Nuclear Medical Market Size and Growth Rate of Industrial
-
5.5.5 China Radiopharmaceuticals in Nuclear Medical Market Size and Growth Rate of Pharmaceutical
Chapter 6 China Radiopharmaceuticals in Nuclear Medical Market, by Region
-
6.1 China Radiopharmaceuticals in Nuclear Medical Production Volume and Production Value, by Region
-
6.2 China Radiopharmaceuticals in Nuclear Medical Sales Volume and Sales Value, by Region
Chapter 7 North China Radiopharmaceuticals in Nuclear Medical Market Analysis
-
7.1 North China Radiopharmaceuticals in Nuclear Medical Market, by Type
-
7.2 North China Radiopharmaceuticals in Nuclear Medical Market, by Application
Chapter 8 Central China Radiopharmaceuticals in Nuclear Medical Market Analysis
-
8.1 Central China Radiopharmaceuticals in Nuclear Medical Market, by Type
-
8.2 Central China Radiopharmaceuticals in Nuclear Medical Market, by Application
Chapter 9 South China Radiopharmaceuticals in Nuclear Medical Market Analysis
-
9.1 South China Radiopharmaceuticals in Nuclear Medical Market, by Type
-
9.2 South China Radiopharmaceuticals in Nuclear Medical Market, by Application
Chapter 10 East China Radiopharmaceuticals in Nuclear Medical Market Analysis
-
10.1 East China Radiopharmaceuticals in Nuclear Medical Market, by Type
-
10.2 East China Radiopharmaceuticals in Nuclear Medical Market, by Application
Chapter 11 Northeast China Radiopharmaceuticals in Nuclear Medical Market Analysis
-
11.1 Northeast China Radiopharmaceuticals in Nuclear Medical Market, by Type
-
11.2 Northeast China Radiopharmaceuticals in Nuclear Medical Market, by Application
Chapter 12 Southwest China Radiopharmaceuticals in Nuclear Medical Market Analysis
-
12.1 Southwest China Radiopharmaceuticals in Nuclear Medical Market, by Type
-
12.2 Southwest China Radiopharmaceuticals in Nuclear Medical Market, by Application
Chapter 13 Northwest China Radiopharmaceuticals in Nuclear Medical Market Analysis
-
13.1 Northwest China Radiopharmaceuticals in Nuclear Medical Market, by Type
-
13.2 Northwest China Radiopharmaceuticals in Nuclear Medical Market, by Application
Chapter 14 Company Profiles
-
14.1 Bracco Imaging
-
14.1.1 Bracco Imaging Company Profile
-
14.1.2 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 IBA Group
-
14.2.1 IBA Group Company Profile
-
14.2.2 IBA Group Radiopharmaceuticals in Nuclear Medical Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Taiyo Nippon Sanso Corporation
-
14.3.1 Taiyo Nippon Sanso Corporation Company Profile
-
14.3.2 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Siemens Healthcare
-
14.4.1 Siemens Healthcare Company Profile
-
14.4.2 Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Ntp Radioisotopes
-
14.5.1 Ntp Radioisotopes Company Profile
-
14.5.2 Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 GE Healthcare (Subsidiary Of General Electric Company)
-
14.6.1 GE Healthcare (Subsidiary Of General Electric Company) Company Profile
-
14.6.2 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Urenco Limited
-
14.7.1 Urenco Limited Company Profile
-
14.7.2 Urenco Limited Radiopharmaceuticals in Nuclear Medical Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Nordion
-
14.8.1 Nordion Company Profile
-
14.8.2 Nordion Radiopharmaceuticals in Nuclear Medical Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Covidien
-
14.9.1 Covidien Company Profile
-
14.9.2 Covidien Radiopharmaceuticals in Nuclear Medical Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Eczacibasi-Monrol
-
14.10.1 Eczacibasi-Monrol Company Profile
-
14.10.2 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Cardinal Health
-
14.11.1 Cardinal Health Company Profile
-
14.11.2 Cardinal Health Radiopharmaceuticals in Nuclear Medical Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Lantheus Medical Imaging
-
14.12.1 Lantheus Medical Imaging Company Profile
-
14.12.2 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Fujifilm Holdings Corporation
-
14.13.1 Fujifilm Holdings Corporation Company Profile
-
14.13.2 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Market Performance
-
14.13.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Radiopharmaceuticals in Nuclear Medical Industry Research Conclusions
-
15.2 Radiopharmaceuticals in Nuclear Medical Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Radiopharmaceuticals in Nuclear Medical Industry Market Size (2018-2029)
-
Figure China Radiopharmaceuticals in Nuclear Medical Production Volume, Production Value and Growth Rate of Enriched Stable Isotopes (2018-2029)
-
Figure China Radiopharmaceuticals in Nuclear Medical Production Volume, Production Value and Growth Rate of Diagnostic Radiopharmaceuticals (2018-2029)
-
Figure China Radiopharmaceuticals in Nuclear Medical Production Volume, Production Value and Growth Rate of Therapy Radiopharmaceuticals (2018-2029)
-
Figure China Radiopharmaceuticals in Nuclear Medical Sales Volume, Sales Value and Growth Rate of Diagnostic Application (2018-2029)
-
Figure China Radiopharmaceuticals in Nuclear Medical Sales Volume, Sales Value and Growth Rate of Research (2018-2029)
-
Figure China Radiopharmaceuticals in Nuclear Medical Sales Volume, Sales Value and Growth Rate of Therapeutic Application (2018-2029)
-
Figure China Radiopharmaceuticals in Nuclear Medical Sales Volume, Sales Value and Growth Rate of Industrial (2018-2029)
-
Figure China Radiopharmaceuticals in Nuclear Medical Sales Volume, Sales Value and Growth Rate of Pharmaceutical (2018-2029)
-
Figure North China Radiopharmaceuticals in Nuclear Medical Market Size and Growth Rate from 2018-2029
-
Figure Central China Radiopharmaceuticals in Nuclear Medical Market Size and Growth Rate from 2018-2029
-
Figure South China Radiopharmaceuticals in Nuclear Medical Market Size and Growth Rate from 2018-2029
-
Figure East China Radiopharmaceuticals in Nuclear Medical Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Radiopharmaceuticals in Nuclear Medical Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Radiopharmaceuticals in Nuclear Medical Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Radiopharmaceuticals in Nuclear Medical Market Size and Growth Rate from 2018-2029
-
Figure Radiopharmaceuticals in Nuclear Medical Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Radiopharmaceuticals in Nuclear Medical Market Share by Type in 2018
-
Figure China Radiopharmaceuticals in Nuclear Medical Market Share by Type in 2023
-
Figure China Radiopharmaceuticals in Nuclear Medical Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Radiopharmaceuticals in Nuclear Medical Production Volume and Growth Rate of Enriched Stable Isotopes (2018-2023)
-
Figure China Radiopharmaceuticals in Nuclear Medical Production Volume and Growth Rate of Diagnostic Radiopharmaceuticals (2018-2023)
-
Figure China Radiopharmaceuticals in Nuclear Medical Production Volume and Growth Rate of Therapy Radiopharmaceuticals (2018-2023)
-
Figure China Radiopharmaceuticals in Nuclear Medical Market Share by Application in 2018
-
Figure China Radiopharmaceuticals in Nuclear Medical Market Share by Application in 2023
-
Figure China Radiopharmaceuticals in Nuclear Medical Total Market Size and Growth Rate from Consumption End
-
Figure China Radiopharmaceuticals in Nuclear Medical Market Size and Growth Rate of Diagnostic Application (2018-2023)
-
Figure China Radiopharmaceuticals in Nuclear Medical Market Size and Growth Rate of Research (2018-2023)
-
Figure China Radiopharmaceuticals in Nuclear Medical Market Size and Growth Rate of Therapeutic Application (2018-2023)
-
Figure China Radiopharmaceuticals in Nuclear Medical Market Size and Growth Rate of Industrial (2018-2023)
-
Figure China Radiopharmaceuticals in Nuclear Medical Market Size and Growth Rate of Pharmaceutical (2018-2023)
-
Table China Radiopharmaceuticals in Nuclear Medical Production Volume by Region (2018-2023)
-
Table China Radiopharmaceuticals in Nuclear Medical Production Volume Share by Region (2018-2023)
-
Figure China Radiopharmaceuticals in Nuclear Medical Production Volume Share by Region (2018-2023)
-
Table China Radiopharmaceuticals in Nuclear Medical Production Value by Region (2018-2023)
-
Table China Radiopharmaceuticals in Nuclear Medical Production Value Share by Region (2018-2023)
-
Figure China Radiopharmaceuticals in Nuclear Medical Production Value Share by Region (2018-2023)
-
Table China Radiopharmaceuticals in Nuclear Medical Sales Volume by Region (2018-2023)
-
Table China Radiopharmaceuticals in Nuclear Medical Sales Volume Share by Region (2018-2023)
-
Figure China Radiopharmaceuticals in Nuclear Medical Sales Volume Share by Region (2018-2023)
-
Table China Radiopharmaceuticals in Nuclear Medical Sales Value by Region (2018-2023)
-
Table China Radiopharmaceuticals in Nuclear Medical Sales Value Share by Region (2018-2023)
-
Figure China Radiopharmaceuticals in Nuclear Medical Sales Value Share by Region (2018-2023)
-
Table North China Radiopharmaceuticals in Nuclear Medical Production Volume by Type (2018-2023)
-
Table North China Radiopharmaceuticals in Nuclear Medical Production Volume Share by Type (2018-2023)
-
Figure North China Radiopharmaceuticals in Nuclear Medical Production Volume Share by Type (2018-2023)
-
Table North China Radiopharmaceuticals in Nuclear Medical Sales Volume by Application (2018-2023)
-
Table North China Radiopharmaceuticals in Nuclear Medical Sales Volume Share by Application (2018-2023)
-
Figure North China Radiopharmaceuticals in Nuclear Medical Sales Volume Share by Application (2018-2023)
-
Table Central China Radiopharmaceuticals in Nuclear Medical Production Volume by Type (2018-2023)
-
Table Central China Radiopharmaceuticals in Nuclear Medical Production Volume Share by Type (2018-2023)
-
Figure Central China Radiopharmaceuticals in Nuclear Medical Production Volume Share by Type (2018-2023)
-
Table Central China Radiopharmaceuticals in Nuclear Medical Sales Volume by Application (2018-2023)
-
Table Central China Radiopharmaceuticals in Nuclear Medical Sales Volume Share by Application (2018-2023)
-
Figure Central China Radiopharmaceuticals in Nuclear Medical Sales Volume Share by Application (2018-2023)
-
Table South China Radiopharmaceuticals in Nuclear Medical Production Volume by Type (2018-2023)
-
Table South China Radiopharmaceuticals in Nuclear Medical Production Volume Share by Type (2018-2023)
-
Figure South China Radiopharmaceuticals in Nuclear Medical Production Volume Share by Type (2018-2023)
-
Table South China Radiopharmaceuticals in Nuclear Medical Sales Volume by Application (2018-2023)
-
Table South China Radiopharmaceuticals in Nuclear Medical Sales Volume Share by Application (2018-2023)
-
Figure South China Radiopharmaceuticals in Nuclear Medical Sales Volume Share by Application (2018-2023)
-
Table East China Radiopharmaceuticals in Nuclear Medical Production Volume by Type (2018-2023)
-
Table East China Radiopharmaceuticals in Nuclear Medical Production Volume Share by Type (2018-2023)
-
Figure East China Radiopharmaceuticals in Nuclear Medical Production Volume Share by Type (2018-2023)
-
Table East China Radiopharmaceuticals in Nuclear Medical Sales Volume by Application (2018-2023)
-
Table East China Radiopharmaceuticals in Nuclear Medical Sales Volume Share by Application (2018-2023)
-
Figure East China Radiopharmaceuticals in Nuclear Medical Sales Volume Share by Application (2018-2023)
-
Table Northeast China Radiopharmaceuticals in Nuclear Medical Production Volume by Type (2018-2023)
-
Table Northeast China Radiopharmaceuticals in Nuclear Medical Production Volume Share by Type (2018-2023)
-
Figure Northeast China Radiopharmaceuticals in Nuclear Medical Production Volume Share by Type (2018-2023)
-
Table Northeast China Radiopharmaceuticals in Nuclear Medical Sales Volume by Application (2018-2023)
-
Table Northeast China Radiopharmaceuticals in Nuclear Medical Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Radiopharmaceuticals in Nuclear Medical Sales Volume Share by Application (2018-2023)
-
Table Southwest China Radiopharmaceuticals in Nuclear Medical Production Volume by Type (2018-2023)
-
Table Southwest China Radiopharmaceuticals in Nuclear Medical Production Volume Share by Type (2018-2023)
-
Figure Southwest China Radiopharmaceuticals in Nuclear Medical Production Volume Share by Type (2018-2023)
-
Table Southwest China Radiopharmaceuticals in Nuclear Medical Sales Volume by Application (2018-2023)
-
Table Southwest China Radiopharmaceuticals in Nuclear Medical Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Radiopharmaceuticals in Nuclear Medical Sales Volume Share by Application (2018-2023)
-
Table Northwest China Radiopharmaceuticals in Nuclear Medical Production Volume by Type (2018-2023)
-
Table Northwest China Radiopharmaceuticals in Nuclear Medical Production Volume Share by Type (2018-2023)
-
Figure Northwest China Radiopharmaceuticals in Nuclear Medical Production Volume Share by Type (2018-2023)
-
Table Northwest China Radiopharmaceuticals in Nuclear Medical Sales Volume by Application (2018-2023)
-
Table Northwest China Radiopharmaceuticals in Nuclear Medical Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Radiopharmaceuticals in Nuclear Medical Sales Volume Share by Application (2018-2023)
-
Table Bracco Imaging Company Profile
-
Table Bracco Imaging Radiopharmaceuticals in Nuclear Medical Revenue, Price and Gross (2018-2023)
-
Table IBA Group Company Profile
-
Table IBA Group Radiopharmaceuticals in Nuclear Medical Revenue, Price and Gross (2018-2023)
-
Table Taiyo Nippon Sanso Corporation Company Profile
-
Table Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Revenue, Price and Gross (2018-2023)
-
Table Siemens Healthcare Company Profile
-
Table Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Revenue, Price and Gross (2018-2023)
-
Table Ntp Radioisotopes Company Profile
-
Table Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Revenue, Price and Gross (2018-2023)
-
Table GE Healthcare (Subsidiary Of General Electric Company) Company Profile
-
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Revenue, Price and Gross (2018-2023)
-
Table Urenco Limited Company Profile
-
Table Urenco Limited Radiopharmaceuticals in Nuclear Medical Revenue, Price and Gross (2018-2023)
-
Table Nordion Company Profile
-
Table Nordion Radiopharmaceuticals in Nuclear Medical Revenue, Price and Gross (2018-2023)
-
Table Covidien Company Profile
-
Table Covidien Radiopharmaceuticals in Nuclear Medical Revenue, Price and Gross (2018-2023)
-
Table Eczacibasi-Monrol Company Profile
-
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Revenue, Price and Gross (2018-2023)
-
Table Cardinal Health Company Profile
-
Table Cardinal Health Radiopharmaceuticals in Nuclear Medical Revenue, Price and Gross (2018-2023)
-
Table Lantheus Medical Imaging Company Profile
-
Table Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Revenue, Price and Gross (2018-2023)
-
Table Fujifilm Holdings Corporation Company Profile
-
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Revenue, Price and Gross (2018-2023)
-
